Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2018 April;70(2) > Minerva Pediatrica 2018 April;70(2):182-4

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Minerva Pediatrica 2018 April;70(2):182-4

DOI: 10.23736/S0026-4946.16.04635-1

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Recent advances in delivery mechanisms for aerosol therapy during pediatric respiratory diseases

Yue’E WU, Chonglin ZHANG , Qing ZHEN

Department of Respiration, Xuzhou Children’s Hospital, Xuzhou, China


PDF


The treatment of pediatric surgery diseases via utilization of aerosol delivery mechanisms is in progress for the betterment of pediatric care. Over the years, aerosol therapy has come to play an integral role in the treatment of pediatric respiratory diseases. Inhaled aerosol agents such as bronchodilators, corticosteroids, antibiotics, and mucolytics are commonly delivered to spontaneously breathing pediatric patients with a tracheostomy. Administering therapeutic inhaled aerosols to pediatric patients is challenging. The pediatric population ranges in age, which means patients with different airway sizes, breathing patterns, and cooperation levels. These patient-related factors impact the deposition of aerosol drugs in the lungs. The present review article will discuss the recent advancements in the delivery mechanisms for aerosol therapy in pediatric patients with respiratory diseases.


KEY WORDS: Aerosols - Administration, inhalation - Respiration disorders - Nebulizers and vaporizers

top of page